96 related articles for article (PubMed ID: 31786304)
21. Impact of age on outcomes following continuous-flow left ventricular assist device implantation.
Lushaj EB; Badami A; Osaki S; Murray M; Leverson G; Lozonschi L; Akhter S; Kohmoto T
Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):743-8. PubMed ID: 25770085
[TBL] [Abstract][Full Text] [Related]
22. Ventricular Assist Device Utilization in Heart Transplant Candidates: Nationwide Variability and Impact on Waitlist Outcomes.
Truby LK; Garan AR; Givens RC; Takeda K; Takayama H; Trinh PN; Yuzefpolskaya M; Farr MA; Naka Y; Colombo PC; Topkara VK
Circ Heart Fail; 2018 Apr; 11(4):e004586. PubMed ID: 29666073
[TBL] [Abstract][Full Text] [Related]
23. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
24. Outcomes in Organ Transplant Recipients With Prostate Cancer Treated With Radiotherapy.
Oh SC; Tariq MB; Reddy CA; Ciezki JP; Stephans KL; Tendulkar RD
Clin Genitourin Cancer; 2019 Feb; 17(1):e162-e166. PubMed ID: 30446400
[TBL] [Abstract][Full Text] [Related]
25. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation.
Sandner SE; Zimpfer D; Zrunek P; Rajek A; Schima H; Dunkler D; Zuckermann AO; Wieselthaler GM
J Heart Lung Transplant; 2009 Apr; 28(4):367-72. PubMed ID: 19332264
[TBL] [Abstract][Full Text] [Related]
26. Left ventricular assist device is protective against cardiac transplant delisting for medical unsuitability.
Cogswell R; Duval S; John R
Int J Cardiol; 2018 Oct; 268():51-54. PubMed ID: 29803342
[TBL] [Abstract][Full Text] [Related]
27. Left ventricular assist devices as bridge to heart transplantation: The Niguarda Experience.
Vitali E; Lanfranconi M; Bruschi G; Russo C; Colombo T; Ribera E
J Card Surg; 2003; 18(2):107-13. PubMed ID: 12757336
[TBL] [Abstract][Full Text] [Related]
28. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
[TBL] [Abstract][Full Text] [Related]
29. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
[TBL] [Abstract][Full Text] [Related]
30. Should patients 60 years and older undergo bridge to transplantation with continuous-flow left ventricular assist devices?
Allen JG; Kilic A; Weiss ES; Arnaoutakis GJ; George TJ; Shah AS; Conte JV
Ann Thorac Surg; 2012 Dec; 94(6):2017-24. PubMed ID: 22858277
[TBL] [Abstract][Full Text] [Related]
31. Outcomes after heart transplantation in sensitized patients bridged with ventricular assist devices.
Fraser CD; Zhou X; Magruder JT; Suarez-Pierre A; Lui C; Grimm JC; Higgins R; Kilic A
J Card Surg; 2019 Jun; 34(6):474-481. PubMed ID: 31045281
[TBL] [Abstract][Full Text] [Related]
32. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
[TBL] [Abstract][Full Text] [Related]
33. Long-term Results of Active Surveillance in the Göteborg Randomized, Population-based Prostate Cancer Screening Trial.
Godtman RA; Holmberg E; Khatami A; Pihl CG; Stranne J; Hugosson J
Eur Urol; 2016 Nov; 70(5):760-766. PubMed ID: 27090975
[TBL] [Abstract][Full Text] [Related]
34. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
[TBL] [Abstract][Full Text] [Related]
35. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
[TBL] [Abstract][Full Text] [Related]
36. Acute and Long-Term Effects of LVAD Support on Right Ventricular Function in Children with Pediatric Pulsatile Ventricular Assist Devices.
Iacobelli R; Di Molfetta A; Brancaccio G; Filippelli S; Morelli S; Natali B; Toscano A; Drago F; Amodeo A
ASAIO J; 2018; 64(1):91-97. PubMed ID: 28509675
[TBL] [Abstract][Full Text] [Related]
37. Simultaneous use of implantable cardioverter-defibrillators and left ventricular assist devices in patients with severe heart failure.
Kühne M; Sakumura M; Reich SS; Sarrazin JF; Wells D; Chalfoun N; Crawford T; Boonyapisit W; Horwood L; Chugh A; Good E; Jongnarangsin K; Bogun F; Oral H; Morady F; Pagani F; Pelosi F
Am J Cardiol; 2010 Feb; 105(3):378-82. PubMed ID: 20102952
[TBL] [Abstract][Full Text] [Related]
38. Implantable left ventricular assist devices: new hope for patients with end-stage heart failure.
Milano CA; Lodge AJ; Blue LJ; Smith PK; Felker GM; Hernandez AF; Rosenberg PB; Rogers JG
N C Med J; 2006; 67(2):110-5. PubMed ID: 16752713
[TBL] [Abstract][Full Text] [Related]
39. Results of new-generation intrapericardial continuous flow left ventricular assist devices as a bridge-to-transplant.
Carrozzini M; Bejko J; Gambino A; Tarzia V; Lanera C; Gregori D; Gerosa G; Bottio T
J Cardiovasc Med (Hagerstown); 2018 Dec; 19(12):739-747. PubMed ID: 30300244
[TBL] [Abstract][Full Text] [Related]
40. Association Between Lead Time and Prostate Cancer Grade: Evidence of Grade Progression from Long-term Follow-up of Large Population-based Cohorts Not Subject to Prostate-specific Antigen Screening.
Assel M; Dahlin A; Ulmert D; Bergh A; Stattin P; Lilja H; Vickers AJ
Eur Urol; 2018 Jun; 73(6):961-967. PubMed ID: 29066048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
